Jim Cramer’s ‘Mad Money’ Lightning Round: Dominion Energy, Dutch Bros, Super Micro Computer, and LyondellBasell

In a recent episode of CNBC’s ‘Mad Money Lightning Round,’ Jim Cramer shared his insights on several stocks. He recommended Dominion Energy as a buy due to the need for cheap power. He also expressed his approval of Dutch Bros’ slowed expansion. Regarding Super Micro Computer, Cramer stated he needed to see the company’s financials before offering an opinion. He did not recommend LyondellBasell Industries. This summary highlights the key takeaways from Cramer’s stock picks, providing context and recent news on each company.

Cramer’s ‘Mad Money’ Lightning Round: Vertiv, AES, NextEra Energy, and Hertz

Jim Cramer on CNBC’s ‘Mad Money Lightning Round’ shared his insights on Vertiv, AES, NextEra Energy, and Hertz. He recommended buying Vertiv, praising its recent sales growth and book-to-bill ratio. He also expressed positive sentiment towards AES, highlighting its affordability. Cramer, however, expressed uncertainty about NextEra Energy, needing more information before forming an opinion. Regarding Hertz, he expressed concern about the company’s recent performance.

Jim Cramer’s ‘Mad Money’ Lightning Round: GE Vernova, Veralto, Eastman Chemical, Lam Research

Jim Cramer shared his insights on GE Vernova, Veralto, Eastman Chemical, and Lam Research during CNBC’s ‘Mad Money Lightning Round’. He expressed optimism about GE Vernova’s potential in the environmental sector and highlighted Veralto’s strong management. Cramer also favored Eastman Chemical as a top plastic stock and advised a cautious approach to Lam Research.

Jim Cramer’s ‘Mad Money’ Lightning Round: Target, Zoetis, PROCEPT, and Con Ed

On CNBC’s ‘Mad Money Lightning Round,’ Jim Cramer shared his insights on Target, Zoetis, PROCEPT BioRobotics, and Consolidated Edison. He praised Target’s strong second-quarter performance and Zoetis’s impressive financial results. While he highlighted the growth potential of PROCEPT BioRobotics, he recommended investors consider Intuitive Surgical (ISRG) instead for robotics investments. Cramer also expressed his continued confidence in Consolidated Edison, citing its consistent performance and attractive dividend yield.

Jim Cramer’s Stock Picks: Ally Financial, Snowflake, Royalty Pharma, and Core Scientific

In a recent episode of CNBC’s ‘Mad Money Lightning Round,’ Jim Cramer shared his thoughts on several stocks, including Ally Financial, Snowflake, Royalty Pharma, and Core Scientific. Cramer recommended buying Ally Financial but was hesitant on Snowflake due to recent downgrades. He expressed disappointment with Royalty Pharma’s performance and labeled Core Scientific as overvalued.

Scroll to Top